Skip to main content

Acute Peripheral Nerve Injuries

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Tissium
TissiumFrance - Paris
1 program
COAPTIUM® CONNECTN/A1 trial
Active Trials
NCT07756489Not Yet Recruiting65Est. Oct 2028

Trial Timeline

Clinical trial activity over time

2026
2027
2028
TissiumCOAPTIUM® CONNECT

Clinical Trials (1)

Total enrollment: 65 patients across 1 trials

NCT07756489TissiumCOAPTIUM® CONNECT

SECURE Post-Market Study

Start: Oct 2026Est. completion: Oct 202865 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.